venlalic xl 37.5mg tablets
ethypharm uk ltd - venlafaxine hydrochloride - modified-release tablet - 37.5mg
venlalic xl 300 mg prolonged-release tablets
ethypharm uk ltd - venlafaxine - prolonged-release tablet - 300 milligram(s) - other antidepressants; venlafaxine
venlalic xl 150mg tablets
waymade healthcare plc - venlafaxine hydrochloride - modified-release tablet - 150mg
venlalic xl 225mg tablets
waymade healthcare plc - venlafaxine hydrochloride - modified-release tablet - 225mg
venlalic xl 37.5mg tablets
waymade healthcare plc - venlafaxine hydrochloride - modified-release tablet - 37.5mg
venlalic xl 75mg tablets
waymade healthcare plc - venlafaxine hydrochloride - modified-release tablet - 75mg
venlalic xl 225mg tablets
pilsco ltd - venlafaxine hydrochloride - modified-release tablet - 225mg
venlabic xr venlafaxine (as hydrochloride) 225 mg modified release capsule
gm pharma international pty ltd - venlafaxine hydrochloride, quantity: 254.7 mg (equivalent: venlafaxine, qty 225 mg) - capsule, modified release - excipient ingredients: microcrystalline cellulose; povidone; purified talc; colloidal anhydrous silica; magnesium stearate; ethylcellulose; copovidone; carmoisine; titanium dioxide; gelatin; propylene glycol; indigo carmine; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution - venlafaxine extended release capsule is indicated for the treatment of: major depression, including prevention of relapse and recurrence where appropriate; generalised anxiety disorder; social anxiety disorder; panic disorder, including prevention of relapse.
venlalic xl 37.5 mg prolonged-release tablets
dallas burston ashbourne ltd. - venlafaxine hydrochloride - tablet prolonged release - 37.5 milligram
venlalic xl 150 mg prolonged-release tablets
dallas burston ashbourne ltd. - venlafaxine hydrochloride - tablet prolonged release - 150 milligram